What is it about?
The way in which different fatty compounds can cause effects in the body can be determined by their different profiles of signalling inside cells. Here we have explored how these profiles differ for a number of fatty compounds found naturally in the body.
Featured Image
Read the Original
This page is a summary of: Endogenous lysophosphatidic acid (LPA1) receptor agonists demonstrate ligand bias between calcium and ERK signalling pathways in human lung fibroblasts, British Journal of Pharmacology, January 2017, Wiley,
DOI: 10.1111/bph.13671.
You can read the full text:
Contributors
The following have contributed to this page







